Pharmacokinetics of rifabutin.

We investigated the pharmacokinetics of rifabutin in 15 male patients as part of a phase I trial of the treatment of early symptomatic human immunodeficiency virus infection. Six or more patients were studied at each of four different oral dosage levels: 300, 600, 900, and 1,200 mg/day. Twelve studi...

Descripción completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Autores principales:	Skinner, M H, Hsieh, M, Torseth, J, Pauloin, D, Bhatia, G, Harkonen, S, Merigan, T C, Blaschke, T F
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 1989
Materias:	Research Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172632/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2552902/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.8.1237
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!